| 12024560 |
Therapeutic agents and methods for enhancing immune responses in tumor microenvironment |
— |
2024-07-02 |
|
| 11976123 |
Anti-CD40 antibodies and uses thereof |
Yi-Ting Wu |
2024-05-07 |
|
| 11505615 |
Anti-CD137 antibodies and uses thereof |
Yi-Ting Wu |
2022-11-22 |
|
| 11203643 |
Humanized anti-CD137 antibodies and uses thereof |
Yi-Ting Wu |
2021-12-21 |
|
| 11186648 |
Anti-CD40 antibody having engineered Fc domains and therapeutic uses thereof |
Yi-Ting Wu |
2021-11-30 |
|
| 10913797 |
Anti-PD-1 antibodies and therapeutic uses thereof |
Liqun Dong, Yaolin Wang |
2021-02-09 |
|
| 10875921 |
Anti-4-1BB antibodies and their uses |
Yoshiko Akamatsu |
2020-12-29 |
|
| 10383948 |
Anti-cMet antibody drug conjugates and methods for their use |
Christian B. Allan, Mark Anderson, Louie Naumovski, Edward B. Reilly |
2019-08-20 |
$652,026,000 |
| 10184003 |
Prolactin receptor binding proteins and uses thereof |
Mark Anderson, Archana Thakur, Debra Chao, Chung-Ming Hsieh, Qian Zhang +6 more |
2019-01-22 |
$459,006,000 |
| 9725515 |
Prolactin receptor binding proteins and uses thereof |
Mark Anderson, Archana Thakur, Debra Chao, Chung-Ming Hsieh, Qian Zhang +1 more |
2017-08-08 |
$470,781,000 |
| 9029508 |
Dual variable domain immunoglobulins and uses thereof |
Tariq Ghayur, Susan Morgan-Lappe, Edward B. Reilly, Gillian A. Kingsbury, Andrew C. Phillips +5 more |
2015-05-12 |
$109,016,000 |
| 8536180 |
Pyrimidine inhibitors of kinase activity |
Richard F. Clark, Nwe Y. Ba-maung, Scott A. Erickson, Steve D. Fidanze, Robert A. Mantei +4 more |
2013-09-17 |
$138,486,000 |
| 8486933 |
Pyrimidine inhibitors of kinase activity |
Gary T. Wang, Robert A. Mantei, Scott A. Erickson, Steve D. Fidanze, George S. Sheppard +1 more |
2013-07-16 |
$103,995,000 |
| 8354422 |
Pyrimidine inhibitors of kinase activity |
Richard F. Clark, Randy L. Bell, Nwe Y. Ba-maung, Scott A. Erickson, Steve D. Fidanze +4 more |
2013-01-15 |
$23,332,000 |
| 8067409 |
Protein kinase inhibitors |
Nwe Y. Ba-maung, Randy L. Bell, Richard F. Clark, Scott A. Erickson, Steve D. Fidanze +5 more |
2011-11-29 |
$29,661,000 |
| 7772231 |
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors |
George S. Sheppard, Gary T. Wang, Fabio Palazzo, Randy L. Bell, Robert A. Mantei +5 more |
2010-08-10 |
$29,784,000 |
| 7495068 |
Antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
Donald J. Davidson, Earl J. Gubbins |
2009-02-24 |
$186,419,000 |
| 7491718 |
Sulfonamides having antiangiogenic and anticancer activity |
Kenneth Comess, Scott A. Erickson, Jack Henkin, Douglas M. Kalvin, Megumi Kawai +13 more |
2009-02-17 |
$139,792,000 |
| 7030262 |
3-Amino-2-hydroxyalkanoic acids and their prodrugs |
Nwe BaMaung, Richard A. Craig, Jack Henkin, Megumi Kawai, Xenia B. Searle +1 more |
2006-04-18 |
$69,029,000 |
| 6887863 |
Hydrazide and alkoxyamide angiogenesis inhibitors |
Richard A. Craig, Megumi Kawai, Linda Lynch, Jyoti R. Patel, George S. Sheppard +3 more |
2005-05-03 |
$71,472,000 |
| 6323228 |
3-substituted indole angiogenesis inhibitors |
Nwe BaMaung, Richard A. Craig, Megumi Kawai |
2001-11-27 |
$360,874,000 |
| 6242494 |
Substituted .beta.-amino acid inhibitors of methionine aminopeptidase-2 |
Richard A. Craig, Jack Henkin, Megumi Kawai, Linda Lynch, Jyoti R. Patel +1 more |
2001-06-05 |
$106,257,000 |
